TNONW Tenon Medical, Inc. - Warrant
NASDAQ · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 13, 2026
$0,01
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$0,0052tyg. minimum
$0,0352tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$2.4K
P/E (TTM)
-0.0
EPS (TTM)
$-12.37
Przychody (TTM)
$5M
Twoje odznaki
Zakres 52 tyg.
$0–$0
Ocena Analityków
·
Cena Docelowa
·
P/E
-0.0
ROE
-551.2%
Marża Zysku Netto
-257.9%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
TNONW Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.01
Kapitalizacja Rynkowa (MRQ)
$2.4K
P/E (TTM)
-0.0
EPS (TTM)
$-12.37
Przychody (TTM)
$5M
ROE (TTM)
-551.2%
Zakres 52 tyg.
$0–$0
TNONW Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$4M2021-12-31 → 2025-12-31
EPS$-1.702021-12-31 → 2025-12-31
Wolny przepływ pieniężny$-11M2022-12-31 → 2025-12-31
Marża netto-257.9%2022-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | TNONW | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -0.0 | · | · | · | |
| P/S (TTM) | 0.0 | · | · | · | |
| P/B (MRQ) | -0.0 | · | · | · | |
| Cena / FCF (TTM) | -0.0 | · | · | · | |
| Cena / Przepływy pieniężne (TTM) | -0.0 | · | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | -0.0 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | TNONW | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 66.8%średnia z 5 lat ≈15.4% | ≈15.4% | · | · | |
| Marża Operacyjna (TTM) | -242.7%średnia z 5 lat ≈-997.8% | ≈-997.8% | · | · | |
| EBITDA Margin (Marża EBITDA) | -324.3%średnia z 5 lat ≈-996.1% | ≈-996.1% | · | · | |
| Marża Zysku Netto (TTM) | -257.9%średnia z 5 lat ≈-1001.3% | ≈-1001.3% | · | · | |
| ROA (TTM) | -130.2%średnia z 5 lat ≈-163.8% | ≈-163.8% | · | · | |
| ROE (TTM) | -551.2%średnia z 5 lat ≈-387.4% | ≈-387.4% | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | TNONW | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 0.6średnia z 5 lat ≈2.9 | ≈2.9 | · | · | |
| Quick Ratio (Wskaźnik Szybkości) | 1.7średnia z 5 lat ≈2.5 | ≈2.5 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | TNONW | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 20.3%średnia z 5 lat ≈172.0% | ≈172.0% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 78.7% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | TNONW | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.4średnia z 5 lat ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Rotacja zapasów) | 1.9średnia z 5 lat ≈3.1 | ≈3.1 | · | · | |
| Receivables Turnover (Rotacja należności) | 3.1średnia z 5 lat ≈5.1 | ≈5.1 | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $4M | $3M | $3M | $691.0K | $160.0K | |
| Cost of Revenue | $2M | $2M | $2M | $1M | $55.0K | |
| Gross Profit | $2M | $2M | $1M | $-641.0K | $105.0K | |
| R&D Expense | $2M | $3M | $3M | $3M | $2M | |
| SG&A Expense | $7M | $8M | $7M | $7M | $3M | |
| Operating Expenses | $15M | $15M | $17M | $18M | $7M | |
| Operating Income | $-13M | $-14M | $-16M | $-19M | $-6M | |
| Interest Expense | · | · | $21.0K | $354.0K | · | |
| Other Non-op | · | $-56.0K | · | $-18.0K | $-620.0K | |
| Pretax Income | · | · | · | $-19M | $-7M | |
| Net Income | $-13M | $-14M | $-16M | $-19M | $-7M | |
| EPS (Basic) | $-1.70 | $-11.26 | $-68.64 | $-23.62 | $-7.81 | |
| EPS (Diluted) | $-1.70 | $-11.26 | $-68.64 | $-23.62 | $-7.81 | |
| Shares (Basic) | 7,384 | 1,214 | 227 | 801 | 903 | |
| Shares (Diluted) | 7,384 | 1,214 | 227 | 801 | 903 | |
| EBITDA | $-13M | $-14M | $-16M | $-19M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $7M | $2M | $2M | $3M | |
| Short-term Investments | · | · | · | $6M | $4M | |
| Receivables | $2M | $863.0K | $518.0K | $228.0K | $76.0K | |
| Inventory | $1M | $606.0K | $554.0K | $415.0K | $188.0K | |
| Prepaid Expense | $260.0K | $206.0K | $389.0K | $134.0K | $87.0K | |
| Current Assets | $7M | $8M | $4M | $9M | $8M | |
| PP&E (Net) | $918.0K | $752.0K | $961.0K | $793.0K | $101.0K | |
| PP&E (Gross) | $2M | $1M | $1M | $873.0K | $103.0K | |
| Accum. Depreciation | $906.0K | $668.0K | $273.0K | $80.0K | $2.0K | |
| Goodwill | $2M | · | · | · | · | |
| Intangibles | $485.0K | · | · | · | · | |
| Total Assets | $11M | $10M | $6M | $11M | $9M | |
| Accounts Payable | $845.0K | $369.0K | $433.0K | $550.0K | $478.0K | |
| Accrued Liabilities | $2M | $910.0K | $808.0K | $717.0K | $1M | |
| Current Liabilities | $3M | $2M | $3M | $3M | $15M | |
| Capital Leases | · | $141.0K | $428.0K | $683.0K | $911.0K | |
| Total Liabilities | $6M | $4M | $6M | $5M | $16M | |
| Common Stock | · | $3.0K | · | $1.0K | $1.0K | |
| Paid-in Capital | $83M | $71M | $56M | $46M | $113.0K | |
| Retained Earnings | $-81M | $-69M | $-55M | $-39M | $-21M | |
| AOCI | · | · | $-46.0K | $-100.0K | $-91.0K | |
| Stockholders' Equity | $5M | $6M | $778.0K | $6M | $-21M | |
| Liabilities + Equity | $11M | $10M | $6M | $11M | $9M | |
| Shares Outstanding | 310,036 | 3,138,804 | 325,039 | 1,123,680 | 989,954 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $262.0K | $408.0K | $199.0K | $78.0K | · | |
| Stock-based Comp | $2M | $4M | $4M | $3M | $377.0K | |
| Other Non-cash | · | · | $-946.0K | · | · | |
| Operating Cash Flow | $-11M | $-10M | $-12M | $-12M | $-4M | |
| CapEx | $273.0K | $186.0K | $361.0K | $847.0K | $102.0K | |
| Investing Cash Flow | $-1M | $-186.0K | $6M | $-3M | $-5M | |
| Stock Issued | · | $2M | $495.0K | $14M | $0 | |
| Net Stock Activity | · | $2M | $5M | $14M | · | |
| Financing Cash Flow | $9M | $14M | $6M | $14M | $11M | |
| Net Change in Cash | $-3M | $4M | $299.0K | $-788.0K | $3M | |
| Taxes Paid | · | · | · | · | $1.0K | |
| Free Cash Flow | $-11M | $-10M | · | $-13M | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | 52.2% | 42.4% | -92.8% | · | |
| Operating Margin | -324.3% | -420.1% | -537.1% | -2709.8% | · | |
| Net Margin | -318.4% | -417.2% | -532.1% | -2737.6% | · | |
| Pretax Margin | · | · | · | -2737.5% | · | |
| EBITDA Margin | -324.3% | -420.1% | -530.3% | -2709.8% | · | |
| ROA | -121.9% | -168.9% | -178.7% | -185.8% | · | |
| ROE | -213.7% | -193.1% | -945.7% | -197.1% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 4.4 | 1.2 | 3.7 | · | |
| Quick Ratio | 1.7 | 4.0 | 0.9 | 3.5 | · | |
| Interest Coverage | · | · | -748.9 | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.1 | · | |
| Inventory Turnover | 1.9 | 2.7 | 3.5 | 4.4 | · | |
| Receivables Turnover | 3.1 | 4.7 | 7.8 | 4.5 | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $0.46 | $1.90 | $0.30 | $0.56 | · | |
| Revenue / Share | $534.13 | $2699.34 | $1614.11 | $86.29 | · | |
| Cash Flow / Share | $-1455.17 | $-8136.74 | $-6716.10 | $-1501.62 | · | |
| Cash / Share | $0.35 | $2.08 | $0.93 | $0.19 | · | |
| EPS (TTM) | $-1.70 | $-11.26 | $-68.64 | $-23.62 | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 20.3% | 11.9% | 323.7% | 331.9% | · | |
| Revenue CAGR 3Y | 78.7% | 173.6% | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $3M | $3M | $691.0K | · | |
| Net Income TTM | $-13M | $-14M | $-16M | $-19M | · | |
| Market Cap | $117.2K | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | |
| P/S | 0.0 | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | |
| P / Tangible Book | 0.1 | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | |
| P / FCF | -0.0 | · | · | · | · | |
| Earnings Yield | -15740.7% | · | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $1M | $1M | $1M | $564.0K | $726.0K | $770.0K | $887.0K | $901.0K | $719.0K | $808.0K | $944.0K | $743.0K | $433.0K | $277.0K | $208.0K | |
| Cost of Revenue | $465.0K | $434.0K | $464.0K | $400.0K | $319.0K | $403.0K | $417.0K | $469.0K | $431.0K | $249.0K | $249.0K | $409.0K | $549.0K | $480.0K | $484.0K | $302.0K | |
| Gross Profit | $814.0K | $945.0K | $1M | $773.0K | $245.0K | $323.0K | $353.0K | $418.0K | $470.0K | $470.0K | $559.0K | $535.0K | $194.0K | $-47.0K | $-207.0K | $-94.0K | |
| R&D Expense | $768.0K | $662.0K | $527.0K | $428.0K | $503.0K | $691.0K | $569.0K | $657.0K | $708.0K | $669.0K | $691.0K | $737.0K | $901.0K | $834.0K | $812.0K | $797.0K | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $8M | $3M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-4M | $-4M | $-3M | $-3M | $-4M | $-5M | $-8M | $-3M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $34.0K | · | $4.0K | · | · | $-8.0K | · | |
| Other Non-op | $132.0K | $-45.0K | · | · | · | · | $0 | · | $7.0K | $-70.0K | · | · | · | · | $-57.0K | $19.0K | |
| Net Income | $-4M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-4M | $-4M | $-3M | $-3M | $-4M | $-5M | $-8M | $-3M | |
| EPS (Basic) | $-12.35 | $-0.31 | $0.07 | $-0.40 | $-12.76 | $-1.01 | $10.55 | $-3.63 | $-8.16 | $-10.02 | $-49.37 | $-11.69 | $-3.28 | $-4.30 | $-17.77 | $-2.82 | |
| EPS (Diluted) | $-12.35 | $0.31 | $0.07 | $-0.40 | $-12.76 | $1.01 | $10.55 | $-3.63 | $-8.16 | $-10.02 | $-49.37 | $-11.69 | $-3.28 | $-4.30 | $-17.77 | $-2.82 | |
| Shares (Basic) | 328 | 11,268 | · | 8,250 | 217 | 3,597 | · | 877 | 469 | 357 | · | 285 | 1,305 | 1,124 | · | 1,124 | |
| Shares (Diluted) | 328 | 11,268 | · | 8,250 | 217 | 3,597 | · | 877 | 469 | 357 | · | 285 | 1,305 | 1,124 | · | 1,124 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-3M | $-4M | · | $-3M | $-4M | $-3M | · | $-3M | $-4M | $-5M | · | $-3M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $4M | $3M | $8M | $10M | $7M | $9M | $2M | $4M | $2M | $3M | $6M | $3M | $2M | $3M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | $493.0K | $2M | $6M | $9M | |
| Receivables | $2M | $2M | $2M | $1M | $770.0K | $886.0K | $863.0K | $876.0K | $679.0K | $571.0K | $518.0K | $773.0K | $601.0K | $316.0K | $228.0K | $144.0K | |
| Inventory | $783.0K | $806.0K | $1M | $1M | $688.0K | $607.0K | $606.0K | $607.0K | $609.0K | $632.0K | $554.0K | $474.0K | $570.0K | $416.0K | $415.0K | $810.0K | |
| Prepaid Expense | $400.0K | $238.0K | $260.0K | $428.0K | $580.0K | $186.0K | $206.0K | $543.0K | $831.0K | $360.0K | $389.0K | $345.0K | $413.0K | $193.0K | $134.0K | $177.0K | |
| Current Assets | $5M | $8M | $7M | $7M | $10M | $12M | $8M | $11M | $4M | $6M | $4M | $5M | $8M | $6M | $9M | $14M | |
| PP&E (Net) | $771.0K | $901.0K | $918.0K | $663.0K | $842.0K | $698.0K | $752.0K | $906.0K | $904.0K | $993.0K | $961.0K | $956.0K | $945.0K | $852.0K | $793.0K | $294.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $957.0K | $873.0K | $349.0K | |
| Accum. Depreciation | $1M | $979.0K | $906.0K | $826.0K | $758.0K | $710.0K | $668.0K | $551.0K | $446.0K | $360.0K | $273.0K | $186.0K | $140.0K | $105.0K | $80.0K | $55.0K | |
| Goodwill | $2M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $455.0K | $470.0K | $485.0K | $500.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $10M | $13M | $11M | $10M | $11M | $13M | $10M | $13M | $6M | $8M | $6M | $7M | $10M | $8M | $11M | $15M | |
| Accounts Payable | $628.0K | $646.0K | $845.0K | $625.0K | $894.0K | $496.0K | $369.0K | $1M | $1M | $266.0K | $433.0K | $763.0K | $912.0K | $928.0K | $550.0K | $422.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $1M | $911.0K | $910.0K | $908.0K | $932.0K | $941.0K | $808.0K | $571.0K | $1M | $530.0K | $717.0K | $603.0K | |
| Current Liabilities | $8M | $7M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $7M | $3M | $3M | $1M | |
| Capital Leases | $1M | $1M | · | · | · | $65.0K | $141.0K | $216.0K | $290.0K | $360.0K | $428.0K | $494.0K | $560.0K | $622.0K | $683.0K | $724.0K | |
| Total Liabilities | $12M | $11M | $6M | $6M | $4M | $4M | $4M | $5M | $5M | $4M | $6M | $5M | $9M | $5M | $5M | $2M | |
| Common Stock | · | $11.0K | $11.0K | $9.0K | $8.0K | $8.0K | $3.0K | $3.0K | $4.0K | $4.0K | · | $2.0K | $22.0K | $11.0K | $1.0K | $11.0K | |
| Paid-in Capital | $84M | $84M | $83M | $80M | $78M | $78M | $71M | $70M | $60M | · | $56M | $55M | $50M | $47M | · | $45M | |
| Retained Earnings | $-89M | $-85M | $-81M | $-78M | $-75M | $-72M | $-69M | $-66M | $-62M | $-59M | $-55M | $-52M | $-49M | $-44M | $-39M | $-32M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $-46.0K | $-102.0K | $-72.0K | $-88.0K | $-100.0K | $-168.0K | |
| Stockholders' Equity | $-2M | $2M | $5M | $5M | $7M | $9M | $6M | $8M | $832.0K | $4M | $778.0K | $3M | $903.0K | $2M | $6M | $13M | |
| Liabilities + Equity | $10M | $13M | $11M | $10M | $11M | $13M | $10M | $13M | $6M | $8M | $6M | $7M | $10M | $8M | $11M | $15M | |
| Shares Outstanding | 330,670 | 11,296,378 | 10,851,273 | 8,605,508 | 7,592,217 | 7,589,965 | 3,138,804 | 3,136,013 | 3,780,827 | 3,726,974 | 325,039 | 2,471,014 | 21,623,769 | 11,251,299 | 1,123,680 | 11,236,801 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $60.0K | $88.0K | $95.0K | $77.0K | $48.0K | $42.0K | $117.0K | $102.0K | $89.0K | $100.0K | · | $46.0K | $35.0K | $25.0K | $25.0K | $24.0K | |
| Stock-based Comp | $412.0K | $331.0K | $344.0K | $58.0K | $417.0K | $872.0K | $883.0K | $910.0K | $1M | $1M | $981.0K | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $120.0K | · | · | · | $189.0K | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-4M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-3M | |
| CapEx | $172.0K | $56.0K | $192.0K | $-111.0K | · | · | $-37.0K | $104.0K | $0 | $119.0K | $92.0K | $57.0K | $128.0K | $84.0K | · | $77.0K | |
| Investing Cash Flow | $-172.0K | $-56.0K | $-192.0K | $-639.0K | · | · | $37.0K | $-104.0K | $0 | $-119.0K | $-92.0K | $436.0K | $1M | $5M | $2M | $-1M | |
| Stock Issued | · | · | · | · | · | · | $-57.0K | $229.0K | $56.0K | $2M | $42.0K | $-4M | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $4M | $3M | $59.0K | $-59.0K | $6M | $113.0K | $10M | $0 | $4M | $1M | $266.0K | $5M | $-42.0K | $-25.0K | $0 | |
| Net Change in Cash | $-3M | $851.0K | $314.0K | $-4M | $-2M | $4M | $-3M | $7M | $-2M | $2M | $-943.0K | $-2M | $3M | $1M | $-1M | $-5M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Free Cash Flow | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | $-4M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.6% | 68.5% | · | 65.9% | 43.4% | 44.5% | · | 47.1% | 52.2% | 65.4% | · | 56.7% | 26.1% | -10.8% | · | -45.2% | |
| Operating Margin | -262.2% | -237.8% | · | -289.2% | -506.6% | -506.5% | · | -362.5% | -429.7% | -487.6% | · | -357.8% | -581.7% | -1128.4% | · | -1568.3% | |
| Net Margin | -316.7% | -252.1% | · | -284.6% | -491.0% | -498.1% | · | -359.0% | -424.6% | -497.4% | · | -353.0% | -576.7% | -1115.5% | · | -1524.5% | |
| EBITDA Margin | -262.2% | -237.8% | · | -289.2% | -506.6% | -506.5% | · | -362.5% | -429.7% | -473.7% | · | -357.8% | -581.7% | -1122.6% | · | -1568.3% | |
| ROA | -38.5% | -26.5% | · | -28.5% | -32.4% | -33.8% | · | -31.3% | -48.2% | -45.7% | · | -29.9% | -30.6% | -65.4% | · | -42.5% | |
| ROE | -163.0% | -61.7% | · | -51.4% | -73.4% | -55.6% | · | -59.5% | -441.0% | -117.3% | · | -43.1% | -53.5% | 47.7% | · | -49.0% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 1.0 | · | 2.2 | 3.9 | 5.5 | · | 3.5 | 1.2 | 2.6 | · | 1.6 | 1.2 | 2.1 | · | 10.8 | |
| Quick Ratio | 0.4 | 0.9 | · | 1.6 | 3.4 | 5.1 | · | 3.2 | 0.8 | 2.2 | · | 1.3 | 1.0 | 1.9 | · | 10.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -103.1 | · | -844.5 | · | · | · | · |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.4 | 0.5 | 0.7 | · | 0.9 | 0.7 | 0.5 | · | 0.6 | 0.9 | 0.9 | · | 0.7 | |
| Receivables Turnover | 0.9 | 1.0 | · | 1.1 | 0.8 | 1.0 | · | 1.1 | 1.4 | 1.6 | · | 2.1 | 2.2 | 2.3 | · | 2.9 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-5.27 | $0.17 | · | $0.56 | $0.88 | $1.24 | · | $2.61 | $0.22 | $0.97 | · | $1.02 | $0.04 | $0.22 | · | $1.15 | |
| Revenue / Share | $3899.39 | $122.38 | · | $142.18 | $74.30 | $201.83 | · | $1011.40 | $240.33 | $252.02 | · | $414.76 | $56.93 | $38.52 | · | $18.51 | |
| Cash Flow / Share | · | $-262.69 | · | · | · | $-690.30 | · | · | · | $-819.49 | · | · | · | $-318.09 | · | · | |
| Cash / Share | $5.07 | $0.41 | · | $0.40 | $1.03 | $1.36 | · | $2.92 | $0.52 | $1.18 | · | $1.36 | $0.27 | $0.28 | · | $0.28 | |
| EPS (TTM) | $-12.37 | $-12.78 | · | $-1.60 | $-4.83 | $-0.23 | · | $-71.18 | $-79.24 | $-74.36 | · | $-37.04 | $-28.17 | $-25.54 | · | $-8.81 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $2M | $2M | $1M | · | $467.0K | |
| Net Income TTM | $-14M | $-12M | · | $-13M | $-13M | $-14M | · | $-14M | $-14M | $-14M | · | $-20M | $-20M | $-21M | · | $-14M | |
| Market Cap | $3.6K | $122.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | -0.0 | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -114537.0% | -118333.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $4M | $3M | $3M | $691.0K | $160.0K |
| Marża Brutto % | 59.8% | 52.2% | 42.4% | -92.8% | · |
| Marża Operacyjna % | -324.3% | -420.1% | -537.1% | -2709.8% | · |
| Zysk netto | $-13M | $-14M | $-16M | $-19M | $-7M |
| Rozwodniony EPS | $-1.70 | $-11.26 | $-68.64 | $-23.62 | $-7.81 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.1 | 4.4 | 1.2 | 3.7 | · |
| Wskaźnik Szybkości | 1.7 | 4.0 | 0.9 | 3.5 | · |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-11M | $-10M | · | $-13M | · |
Właściciele instytucjonalni (13F) 10 emitentów · $90K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
10
Wartość posiadanych akcji
$90K
Nowe pozycje
0
Zamknięte pozycje
2
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 0 (-5 vs poprzedni kw.) | 2 (+1 vs poprzedni kw.) | 2 (0 vs poprzedni kw.) | 3 (+3 vs poprzedni kw.) | +4.6M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Focus Partners Wealth | $50 976 | 4 720 000 | 56,40% | Akcje |
| CLEAR STREET LLC | $17 541 | 953 294 | 19,41% | Akcje |
| Clear Street Group Inc. | $10 290 | 952 794 | 11,38% | Akcje |
| Spectrum Asset Management, Inc. (NB/CA) | $7 338 | 679 420 | 8,12% | Akcje |
| HEIGHTS CAPITAL MANAGEMENT, INC | $1 515 | 140 236 | 1,68% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $1 415 | 131 000 | 1,57% | Akcje |
| CITADEL ADVISORS LLC | $839 | 70 499 | 0,93% | Akcje |
| ARMISTICE CAPITAL, LLC | $240 | 22 250 | 0,27% | Akcje |
| GTS SECURITIES LLC | $231 | 21 044 | 0,26% | Akcje |
| UBS Group AG | $5 | 499 | 0,01% | Akcje |
Insiderzy spółki 9 insiderów · 3 dyrektorzy generalni · 7 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Steven M Foster | CEO and President | 31 lipca 2026 M | 262 962 | 0 | 0 | $0 |
| Kevin Williamson | Chief Financial Officer | 8 września 2026 M | 2 580 | 0 | 0 | $0 |
| Richard Ginn | Chief Technology Officer | 31 lipca 2026 M | 167 357 | 0 | 0 | $0 |
| Kristine M Jacques | Dyrektor | 31 lipca 2026 M | 20 876 | 0 | 0 | $0 |
| Robert K Weigle | Dyrektor | 31 lipca 2026 M | 18 284 | 0 | 0 | $0 |
| Ivan Howard | Dyrektor | 31 lipca 2026 M | 19 194 | 0 | 0 | $0 |
| Stephen Hochschuler | Dyrektor | 31 lipca 2026 M | 18 670 | 0 | 0 | $0 |
| Richard Ferrari | Dyrektor | 31 lipca 2026 M | 135 243 | 0 | 0 | $0 |
| HRT FINANCIAL LP | Posiadacz 10% | 10 września 2026 S | 15 839 | 9 | 9 | $-105 445 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 13, 2026